Source: Reproductive Sciences. Unidade: FMRP
Subjects: ENDOMETRIOSE, NEOVASCULARIZAÇÃO PATOLÓGICA, FÁRMACOS, EXPRESSÃO GÊNICA, ANTICORPOS MONOCLONAIS
ABNT
ZANI, Ana Carolina Tagliatti et al. Impact of Bevacizumab on experimentally induced endometriotic lesions: angiogenesis, invasion, apoptosis, and cell proliferation. Reproductive Sciences, v. 27, n. 10, p. 1943-1950, 2020Tradução . . Disponível em: https://doi.org/10.1007/s43032-020-00213-7. Acesso em: 28 out. 2024.APA
Zani, A. C. T., Valério, F. P., Meola, J., Ribeiro-Silva, A., Nogueira, A. A., Reis, F. J. C. dos, et al. (2020). Impact of Bevacizumab on experimentally induced endometriotic lesions: angiogenesis, invasion, apoptosis, and cell proliferation. Reproductive Sciences, 27( 10), 1943-1950. doi:10.1007/s43032-020-00213-7NLM
Zani ACT, Valério FP, Meola J, Ribeiro-Silva A, Nogueira AA, Reis FJC dos, Poli Netto OB, Rosa e Silva JC. Impact of Bevacizumab on experimentally induced endometriotic lesions: angiogenesis, invasion, apoptosis, and cell proliferation [Internet]. Reproductive Sciences. 2020 ; 27( 10): 1943-1950.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s43032-020-00213-7Vancouver
Zani ACT, Valério FP, Meola J, Ribeiro-Silva A, Nogueira AA, Reis FJC dos, Poli Netto OB, Rosa e Silva JC. Impact of Bevacizumab on experimentally induced endometriotic lesions: angiogenesis, invasion, apoptosis, and cell proliferation [Internet]. Reproductive Sciences. 2020 ; 27( 10): 1943-1950.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s43032-020-00213-7